Persistence to disease-modifying therapies for multiple sclerosis in a Canadian cohort
Persistence to disease-modifying therapies for multiple sclerosis in a Canadian cohort
About this item
Full title
Author / Creator
Publisher
New Zealand: Dove Medical Press Limited
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Dove Medical Press Limited
Subjects
More information
Scope and Contents
Contents
To examine the long-term persistence to the first-line injectable disease-modifying therapies (DMTs) for multiple sclerosis (MS) and to identify the factors associated with nonpersistence.
We used population-based administrative data from Manitoba, Canada. All adult subjects who were diagnosed with MS and dispensed a first-line injectable DMT (b...
Alternative Titles
Full title
Persistence to disease-modifying therapies for multiple sclerosis in a Canadian cohort
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5499788
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5499788
Other Identifiers
ISSN
1177-889X
E-ISSN
1177-889X
DOI
10.2147/PPA.S138263
